The natural compound orotic acid and its anionic form, orotate, play a pivotal role in various biological processes, serving as essential intermediates in pyrimidine de novo synthesis, with demonstrated connections to dietary, supplement, and neurodrug applications. A novel perspective on biomolecular aggregation at the nanoscale, particularly pertinent to neurodegeneration, challenges the established paradigm positing that peptide (amyloid beta) and protein (tau) aggregation mainly govern the molecular events underlying prevalent neuropathologies. Emerging biological evidence indicates a notable role for G‐quadruplex (G4) DNA aggregation in neurodegenerative processes affecting neuronal cells, particularly in the presence of extended (G4C2)n repeats in nuclear DNA sequences. Our study concerns d[(GGGGCC)3GGGG], a G4‐forming DNA model featuring G4C2 repeats that is in correlation with neurodegeneration. Through different investigations utilizing spectroscopic techniques (CD, UV, and thermal denaturations), PAGE electrophoresis, and molecular docking, the study explores the influence of orotate on the aggregation of this neurodegeneration‐associated DNA. A computational approach was employed to construct an in silico model of the DNA aggregate, which involved the docking of multiple G4 units and subsequent integration of the ligand into both the DNA monomer and its in silico aggregated model. The convergence of computational analyses and empirical data collectively supports the hypothesis that orotate possesses the capability to modulate the aggregation of neurodegeneration‐related DNA. Notably, the findings suggest the potential utility of orotate as a neurodrug, especially for the therapy of amyotrophic lateral sclerosis (ALS) and Frontotemporal Dementia (FTD), with its current status as a dietary supplement indicating minimal safety concerns. Additionally, orotate demonstrated a slight increase in mitochondrial dehydrogenase activity as assessed by the MTT assay, which is beneficial for a neurodrug as it suggests a potential role in enhancing mitochondrial function and supporting neuronal health. image
The ON 1, bearing the lipophilic TBDPS groups at both 5′ ends, produces − after the annealing procedure in K+-containing buffer − the highly lipophilic G-quadruplex 2, which spontaneously assembles into ordered G4 aggregates.
Herein, we investigated the binding properties of four natural compounds extracted from Mediterranean plants—distachyasin, CxB, CxC, and magnoflorine—toward the G-quadruplex (GQ) formed by the KRAS22-RT sequence, a modified KRAS-derived oligonucleotide commonly used as a model of the KRAS oncogene, which adopts a single, well-defined parallel intramolecular GQ structure. Circular dichroism (CD) and nuclear magnetic resonance (NMR) spectroscopies revealed that distachyasin, CxC, and mag-noflorine induced only a slight stabilization of the GQ. In contrast, CxB significantly increased the GQ melting temperature, indicating a markedly stronger stabilizing effect. Notably, the reduced stabilizing effect of its diastereomer CxC highlights how the spatial arrangement of substituents around the core structure can strongly influence the binding properties of ligands towards GQs. Finally, the compounds were evaluated in three breast cancer cell lines and showed antiproliferative effects, particularly in the drug-resistant model.